aDivision of Health Services Research, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States
bCenter for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System, Little Rock, AR, United States
cCenter for Care Delivery and Outcomes Research, Minneapolis VA Healthcare System, Minneapolis, MN, United States
dDepartment of Medicine, University of Minnesota Medical School, Minneapolis, MN, United States
eDepartment of Pharmaceutical Outcomes and Policy, Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida, Gainesville, FL, United States
fDivision of Pharmaceutical Evaluation and Policy, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, United States
*Corresponding author. Address: Division of Pharmaceutical Evaluation and Policy, College of Pharmacy, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 522, Little Rock, AR 72205, United States. Tel.: (501) 603-1992; fax: (501) 686-5156. E-mail address: [email protected] (B.C. Martin).
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.painjournalonline.com).
